Strategic Partnerships Leverage Sonic's ongoing companion diagnostics collaborations to accelerate US market access for CDx programs, offering joint development, validation support, and shared go-to-market opportunities with CellCarta and BCAL Diagnostics.

Oncology Expansion Target the expanding hematology and oncology testing portfolio by offering high-complexity panels, workflow optimization, and turnkey lab setup for newly acquired or expanded facilities, aligning with Sonic's national growth in the US.

Biomarker Leadership Capitalize on proteomics and PromarkerD licensing activity to bring biomarker assays and CDx solutions to the US, providing development, validation, regulatory support, and data analytics for pharma and clinical customers.

Infectious Disease Readiness Expand infectious disease capabilities beyond existing programs to include multiplex panels and rapid deployment of new assays across community labs, leveraging the federated network for scalable outbreak response.

Global Trials & Services Promote cross-border reference testing, international trial support, and standardized quality programs to CROs and biopharma, leveraging Sonic's global footprint and integrated data exchange to win multinational contracts.